Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 450 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$91.33M
Gross Margin
87.06%
TTM Avg
85.86%
3Y Avg
83.85%
5Y Avg
76.72%
Market Cap
$88.21M
Gross Margin
40.32%
TTM Avg
35.69%
3Y Avg
34.43%
5Y Avg
37.90%
Market Cap
$87.86M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$100.37M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
5.83%
5Y Avg
8.02%
Market Cap
$84.75M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.70M
Gross Margin
82.44%
TTM Avg
83.07%
3Y Avg
-40.55%
5Y Avg
-241.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $93.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | 50.00% | 75.00% | 50.00% |
| electroCore, Inc. (ECOR)vs › | $91.33M | 87.06% | 85.86% | 83.85% | 76.72% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 40.32% | 35.69% | 34.43% | 37.90% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | 100.00% | 100.00% | 100.00% | 100.00% |
| Anixa Biosciences, Inc. (ANIX)vs › | $100.37M | 0.00% | 0.00% | 5.83% | 8.02% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 46.51% | 45.81% | 42.58% | 41.06% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 82.44% | 83.07% | -40.55% | -241.44% |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -736.46% | -368.23% | -290.99% | -1574.61% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
